Skip to main content
. 2016 Mar 10;31(4):553–560. doi: 10.3346/jkms.2016.31.4.553

Table 1. Baseline characteristics of the KOCOSS subjects.

Variables No. of subjects No. (%) or observation
Age (yr, mean ± SD) 956 69.9 ± 7.8
Male, No. (%) 956 872 (91.2)
BMI (kg/m2, mean ± SD) 926 22.7 ± 3.4
Smoking, pack/yr, (mean ± SD) 812 43.9 ± 25.1
 Current smoker (%) 938 262 (27.9)
 Former smoker (%) 596 (63.5)
 Non – smoker (%) 80 (8.5)
Number of acute exacerbation during one year before enroll 942
 Mean number (mean ± SD) 0.58 ± 1.6
 0 (%) 692 (73.5)
 1 (%) 145 (15.4)
 ≥ 2 (%) 105 (11.2)
Number of comorbidities (mean ± SD) 958 1.7 ± 1.4
 0 208 (21.7)
 1 256 (26.7)
 2 258 (26.9)
 3 145 (15.1)
 4 51 (55.3)
 5 28 (2.92)
 6 7 (0.7)
 7 5 (0.5)
Education level 945
 Middle school and below 540 (57.1)
 High school 280 (29.6)
 College and above 125 (13.2)
Lung function
 FEV1/FVC (%, mean ± SD) 916 49.0 ± 12.0
 Post bronchodilator FEV1 (%, mean ± SD) 914 55.8 ± 16.7
 Post bronchodilator FEV1 (L, mean ± SD) 923 1.5 ± 0.58
 FVC (L, mean ± SD) 923 3.06 ± 0.79
 TLC (L, mean ± SD) 596 5.6 ± 0.8
6MWD (meters, mean ± SD) 737 365.6 ± 117.3
Subjects requiring oxygen during/after 6MWD 958 2 (0.3)
Symptom scores 958
 CAT (mean ± SD) 913 15.5 ± 7.7
  CAT score 213 (23.3)
  CAT score ≥ 10 700 (76.7)
 mMRC score (mean ± SD) 951 1.6 ± 1.0
  mMRC score 515 (54.2)
  mMRC score ≥ 2 436 (45.8)
Questionnaire (SGRQ-C)
 Symptom 947 44.2 ± 20.9
 Activity 946 46.0± 27.3
 Impact 947 25.7 ± 23.3
 Total 944 34.8 ± 19.6
GOLD stage (I to IV) 914
 I 51 (5.6)
 II 520 (56.9)
 III 291 (31.8)
 IV 52 (5.7)
GOLD (A to D) 920
 A 122 (12.8)
 B 399 (42.0)
 C 48 (5.1)
 D 351 (36.9)

SD, standard deviation; BMI, body mass index; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; TLC, total lung capacity; 6MWD, six minutes walk distance test; CAT, COPD assessment test; mMRC, modified Medical Research Council dyspnea scale; SGRQ-C, St. George’s respiratory questionnaire; GOLD, global initiative for chronic obstructive lung disease.